Crest Clinical Study Supports Triclosan Antigingivitis Efficacy – Ciba
This article was originally published in The Rose Sheet
Executive Summary
A clinical trial conducted in China on a triclosan-containing toothpaste marketed under the Crest brand demonstrates an improvement in the bleeding index of subjects, supporting the ingredient's antigingivitis efficacy, Ciba states in an Oct. 1 1submission to FDA